pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,490 catalysts · 3,315 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 31 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-02×clear all
type
  • 8k filing3,315
  • grant1,096
  • device adverse event1,000
  • earnings580
  • approval550
  • device 510k430
device pma
248
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 2, 2026

    50
    ›Mar 5, 2026grant163d agoBRIGHAM AND WOMEN'S HOSPITAL — Cellular Therapy for Sepsis and Lung InjuryBrigham and Women's Hospital

    GM grant. $445,983. PI: Mark A PERRELLA

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Mechanisms that regulate cellular responses to phosphate

    GM grant. $429,000. PI: Lauren Elizabeth Surface

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoPENNSYLVANIA STATE UNIVERSITY, THE — Investigating brain-body allostasis via longitudinal in vivo imaging

    GM grant. $407,603. PI: Grayson Oren Sipe

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF MARYLAND BALTIMORE — SGLT2 - Novel Molecular Mechanism of AQP4 Regulation

    NS grant. $602,065. PI: J. Marc Simard

    full page →nih reporter ↗
    ›Mar 6, 2026approval162d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

    Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →risankizumab →fda approvals ↗
    ›Mar 6, 2026approval162d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

    Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION

    full page →risankizumab →fda approvals ↗
    ›Mar 6, 2026approval162d agoQUDEXY XR (TOPIRAMATE) — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoPYLARIFY TRUVU (PIFLUFOLASTAT F-18) — FDA approval

    Sponsor: APHELION. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

    Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

    full page →Restasis →fda approvals ↗
    ›Mar 6, 2026approval162d agoQSYMIA (PHENTERMINE HYDROCHLORIDE) — FDA approval(phentermine hydrochloride + topiramate) ER

    Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →(phentermine hydrochloride + topiramate) ER →fda approvals ↗
    ›Mar 6, 2026approval162d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoXELJANZ XR (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

    Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Mar 6, 2026approval162d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvalBiocon Pharma Ltd

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →PHYTONADIONE →fda approvals ↗
    ›Mar 6, 2026approval162d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →PHYTONADIONE →fda approvals ↗
    ›Mar 6, 2026approval162d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoSIPONIMOD — FDA approvalSIPONIMOD

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →SIPONIMOD →fda approvals ↗
    ›Mar 6, 2026approval162d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Mar 6, 2026approval162d agoSOTYKTU (DEUCRAVACITINIB) — FDA approvalBristol-Myers Squibb Co

    Sponsor: BRISTOL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoTROKENDI XR (TOPIRAMATE) — FDA approvalSUPERNUS PHARMACEUTICALS, INC.

    Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoNICARDIPINE HYDROCHLORIDE — FDA approvalNICARDIPINE HYDROCHLORIDE

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

    full page →NICARDIPINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 6, 2026approval162d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: PRINSTON INC. Form: CAPSULE. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Mar 6, 2026approval162d agoEVEROLIMUS — FDA approvalEVEROLIMUS

    Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

    full page →EVEROLIMUS →fda approvals ↗
    ›Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

    Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION

    full page →Restasis →fda approvals ↗
    ›Mar 6, 2026approval162d agoEPRONTIA (TOPIRAMATE) — FDA approvaltopiramate ER

    Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

    full page →topiramate ER →fda approvals ↗
    ›Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

    Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

    full page →Restasis →fda approvals ↗
    ›Mar 6, 2026approval162d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

    Sponsor: PFIZER. Form: SOLUTION. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Mar 6, 2026device 510k162d agoTreace Medical Concepts, Inc. — Treace Medical Concepts (TMC) Screw Fixation System (510k cleared)TREACE MEDICAL CONCEPTS, INC.

    Product code: HWC. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoOlympus Medical Systems Corp. — Single Use Electrosurgical Hemostatic Forceps FD-410LR, FD-411UR, FD-412LR (510k cleared)

    Product code: KGE. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoTheramicro — TeKBrace Knotless Anchor (510k cleared)

    Product code: MBI. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoZhejiang Chuangxiang Medical Technology Co., Ltd. — Single use stone retrieval balloons (510k cleared)Zhejiang Xinkanghe Biomedical Technology Co Ltd

    Product code: FGE. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoGuangzhou Potent Medical Equipment Joint-Stock Co., Ltd. — Holmium Laser Therapeutic Apparatus (HZ-A); Holmium Laser Therapeutic Apparatus (HZ-B); Holmium Laser Therapeutic Apparatus (HZ-E) (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoBunkerHill Health — Bunkerhill Contrast AVC (510k cleared)

    Product code: JAK. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoCalyxo, Inc. — CVAC Image Processor (510k cleared)

    Product code: FGB. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoAdeor Medical AG — Velocity Alpha MR High Speed Surgical Drill System (510k cleared)

    Product code: HBB. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoNano4imaging GmbH — EmeryGlide™ (EG18008901) (510k cleared)

    Product code: DQX. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoFord Medtech, LLC — JFord Speculum Sleeve™ (510k cleared)

    Product code: HIB. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoHudens Bio Co., Ltd. — BONTREE PLUS (510k cleared)

    Product code: LYC. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoBunkerHill Health — Bunkerhill Contrast CAC (510k cleared)

    Product code: JAK. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoDepuy Ireland UC — VELYS™ Hip Navigation (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device 510k162d agoGuangzhou Haoyimai Trading Co., Ltd. — Water-based lubricant (510k cleared)

    Product code: NUC. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 6, 2026device pma162d agoKestra Medical Technologies, Inc. — ASSURE Wearable Cardioverter Defibrillator (WCD) System (PMA supplement)KESTRA MEDICAL TECHNOLOGIES, LTD.

    Supplement type: Normal 180 Day Track. Product code: MVK. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 6, 2026device pma162d agoEuclid Vision Corporation — Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear, Euclid Orthokeratology (tisilfocon A) Contact Le (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: NUU. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ›Mar 6, 2026device pma162d agoMedtronic, Inc. — HV Splitter/ Adaptor kit (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NVY. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 6, 2026device pma162d agoBiomet Manufacturing Corp — Oxford Cementless Partial Knee System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NRA. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Mar 6, 2026device pma162d agoMedtronic Cardiac Rhythm Disease Management — Cobalt MRI ICD; Cobalt XT MRI ICD; Crome MRI ICD; Evera MRI DF-1 ICD; Evera MRI ICD; Evera S DR ICD; Evera S VR I CD; Ev (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 6, 2026device pma162d agoABBOTT MEDICAL — TriClip G4 System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NPS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 6, 2026device pma162d agoMedtronic Cardiac Rhythm Disease Management — SelectSecure Lead (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 6, 2026device pma162d agoMedtronic, Inc. — IN.PACT™ 018 Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter (PMA supplement)Medtronic plc

    Supplement type: Normal 180 Day Track. Product code: ONU. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 6, 2026device pma162d agoBoston Scientific — ENDOTAK RELIANCE™ / RELIANCE 4-FRONT™ pace/sense defibrillation leads (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Normal 180 Day Track No User Fee. Product code: LWS. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ← prev
    page 6 of 150
    next →
    $NVS150.18-1.01%
    $AMRX17.66+2.26%
    $TMCI4.1900+4.49%
    $PFE26.61-0.73%
    $SUPN48.02+1.85%
    $NVS150.18-1.01%
    $NVS150.18-1.01%
    $ABBV250.05-0.31%
    $ABBV250.05-0.31%
    $PFE26.61-0.73%
    $KMTS20.35+8.13%
    $MDT90.58-0.20%
    $MDT90.58-0.20%
    $BSX52.44+1.44%